Drugs / NP-018
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00360737 | Jul → Dec 2006 | — | Emergent BioSolutions | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NP-018 | “NP-018 (heptavalent equine-derived botulinum antitoxin) is prepared from plasma obtained from horses” NCT00360737 ↗ |
| Modality | Protein / enzyme biologic | “human or equine derived antibodies” NCT00360737 ↗ |
| Route | Intravenous | “administered intravenously” NCT00360737 ↗ |